|
|
|
| Association between KLB gene and susceptibility to sarcopenia among the elderly |
| GU Xue, LI Fudong, XU Le, ZHANG Tao, ZHAI Yujia, HE Fan
|
| Department of Public Health Surveillance and Advisory, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China |
|
|
|
|
Abstract Objective To examine the associations of fibroblast growth factor 19 (FGF19), its co-receptor KLB gene and its receptor FGFR4 with susceptibility to sarcopenia, so as to provide insights into elucidation of sarcopenia pathogenesis and formulation of precision interventions for sarcopenia. Methods A case-control study was conducted. Patients with sarcopenia at ages of 60 years and older included in the Zhejiang Provincial Elderly Health Surveillance Cohorts were selected as the sarcopenia group, and normal residents at ages of 60 years and older were served as controls. Subjects' demographics were collected using questionnaire surveys, and the height, body weight, appendicular skeletal muscle mass and grip strength were measured. Genomic DNA was extracted from blood samples for multiplex PCR targeted capture. The associations between the KLB gene single-nucleotide polymorphisms (SNPs) and susceptibility to sarcopenia were evaluated using multivariable logistic regression models. Results There were 200 cases in the sarcopenia group, including 91 men and 109 women, and 180 cases in the control group, including 70 men and 110 women. All SNPs satisfied the Hardy-Weinberg equilibrium, and the minor allele frequencies were all > 0.05. There were no significant differences in the distribution of SNPs between the sarcopenia and control groups (all P>0.05). Multivariable logistic regression analysis showed that the SNP rs2687968 locus in the KLB gene was significantly associated with the susceptibility to sarcopenia among the elderly men (superdominant model), and individuals carrying the AC allele had a 2.332-fold higher risk of sarcopenia than those carrying the AA/CC allele (95%CI: 1.882-3.313). Conclusion KLB gene may correlate with the susceptibility to sarcopenia among the elderly men.
|
|
Received: 06 May 2023
Revised: 07 August 2023
Published: 10 October 2023
|
|
|
|
|
|
[1] ANKER S D,MORLEY J E,VON HAEHLING S.Welcome to the ICD-10 code for sarcopenia[J].J Cachexia Sarcopenia Muscle,2016,7(5):512-514.
[2] MAYHEW A J,AMOG K,PHILLIPS S,et al.The prevalence of sarcopenia in community-dwelling older adults,an exploration of differences between studies and within definitions:a systematic review and meta-analyses[J].Age Ageing,2019,48(1):48-56.
[3] GAO L L,JIANG J J,MING Y,et al.Prevalence of sarcopenia and associated factors in Chinese community-dwelling elderly:comparison between rural and urban areas[J/OL].J Am Med Dir Assoc,2015,16(11)[2023-08-07].https://doi.org/10.1016/j.jamda.2015.07.020.
[4] WANG H,HAI S,CAO L,et al.Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people[J/OL].BMC Geriatr,2016,16(1)[2023-08-07].https://doi.org/10.1186/s12877-016-0386-z.
[5] DENNISON E M,SAYER A A,COOPER C.Epidemiology of sarcopenia and insight into possible therapeutic targets[J].Nat Rev Rheumatol,2017,13(6):340-347.
[6] YOU J Y,KIM Y J,SHIN W Y,et al.Heritability of muscle mass in Korean parent-offspring pairs in the Fifth Korean National Health and Nutrition Examination Survey(KNHANES V)[J].Maturitas,2018,114:67-72.
[7] KARASIK D,KIEL D P.Evidence for pleiotropic factors in genetics of the musculoskeletal system[J].Bone,2010,46(5):1226-1237.
[8] TAN L J,LIU S L,LEI S F,et al.Molecular genetic studies of gene identification for sarcopenia[J].Hum Genet,2012,131(1):1-31.
[9] LIVSHITS G,GAO F,MALKIN I,et al.Contribution of heritability and epigenetic factors to skeletal muscle mass variation in United Kingdom twins[J].J Clin Endocrinol Metab,2016,101(6):2450-2459.
[10] BENOIT B,MEUGNIER E,CASTELLI M,et al.Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice[J].Nat Med,2017,23(8):990-996.
[11] TALUKDAR S,KHARITONENKOV A.FGF19 and FGF21:in NASH we trust[J/OL].Mol Metab,2021,46[2023-08-07].https://doi.org/10.1016/j.molmet.2020.101152.
[12] LIN J F,LI F D,CHEN X G,et al.Association of postlunch napping duration and night-time sleep duration with cognitive impairment in Chinese elderly:a cross-sectional study[J/OL].BMJ Open,2018,8(12)[2023-08-07].http://dx.doi.org/10.1136/bmjopen-2018-023188.
[13] WU X,GE H,BARIBAULT H,et al.Dual actions of fibroblast growth factor 19 on lipid metabolism[J].J Lipid Res,2013,54(2):325-332.
[14] FU L,JOHN L M,ADAMS S H,et al.Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin deficient diabetes[J].Endocrinology,2004,145(6):2594-2603.
[15] TOMLINSON E,FU L,JOHN L,et al.Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity[J].Endocrinology,2002,143(5):1741-1747.
[16] POTTHOFF M J,BONEY M J,CHOI M,et al.FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB PGC 1 alpha pathway[J].Cell Metab,2011,13(6):729-738.
[17] NICHOLES K,GUILLET S,TOMLINSON E,et al.A mouse model of hepatocellular carcinoma:ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice[J].Am J Pathol,2002,160(6):2295-2307. |
|
|
|
